Register for real-time alerts, custom portfolio, and market movers
The current BCYC market cap is 1.4B. The company's latest EPS is USD -2.6166 and P/E is -7.70.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.35M | 5.33M | 19.53M | 9.36M | 2.68M |
| Operating Income | -66.57M | -38.83M | -31.72M | -38.91M | -82.83M |
| Net Income | -49.9M | -49.1M | -26.56M | -39.81M | -50.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.8M | 10.39M | 11.7M | 14.46M | 26.98M |
| Operating Income | -26.3M | -51.96M | -65.62M | -106.26M | -174.54M |
| Net Income | -30.61M | -51.01M | -66.82M | -112.72M | -180.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 638.68M | 595.34M | 547.14M | 1.06B | 996.75M |
| Total Liabilities | 222.66M | 224.41M | 191.1M | 183.54M | 165.71M |
| Total Equity | 416.02M | 370.93M | 356.05M | 873.81M | 831.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.19M | 161.15M | 479.79M | 410.61M | 595.34M |
| Total Liabilities | 17M | 65.69M | 133.54M | 139.83M | 224.41M |
| Total Equity | 93.2M | 95.46M | 346.25M | 270.78M | 370.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.34M | -60.63M | -70.87M | -115.5M | -155.33M |
| Investing | -2.88M | -2.93M | -12k | -432k | -867k |
| Financing | 249.64M | 250.03M | 1.87M | 551.48M | 519.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -28.61M | -17.79M | -14.79M | -86.11M | -60.63M |
| Investing | -1.56M | -1.2M | -2.03M | -18.99M | -2.93M |
| Financing | 58.44M | 62.84M | 320.73M | 6.69M | 250.03M |
| Market Cap | 1.4B |
| Price to Earnings Ratio | -7.70 |
| Price to Sales Ratio | 51.6 |
| Price to Cash Ratio | 2.64 |
| Price to Book Ratio | 3.75 |
| Dividend Yield | - |
| Shares Outstanding | 69.05M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.17 (0.83%) |
| Company Name | Bicycle Therapeutics PLC |
| Address |
b900 cambridge CB22 3AT |
| Website | https://www.bicycletherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
